Article
Drug-resistant extracellular vesicles: a reliable biomarker for predicting therapeutic response in patients with triple-negative breast cancer receiving neoadjuvant chemotherapy
2022-11-04
Abstract excerpt
<h4>Background: </h4> Predicting tumor response for neoadjuvant chemotherapy (NAC) is critical for evaluating prognosis and deciding the treatment strategy in patients with breast cancer; however, there are no reliable circulating biomarkers that can assess therapeutic responses appropriately and effectively. Therefore, we aimed to validate the clinical feasibility of extracellular vesicles (EV) collected through...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- aa5a4ce5-fe7d-5bdb-9743-c13d1f814d53
- DOI
- 10.21203/rs.3.rs-2200956/v1
